CB43829-23 - 0x0000000000006597

Overweight Males & Females

Cardinal

* Stipend may pay up to reflected amount.
Start Date: 
May 13, 2025 - 3:00pm
End Date: 
July 2, 2025 - 9:30am

Study Details

Study Number: CB43829
Group Number: 23
Study Requirement: Obese
Stipend: up to $12,000.00

Study Criteria

Age: 19 - 55
BMI: 27 - 39.9
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat obesity.
Route of Administration: Injection subcutaneous
Blood Draws: 21

Study Schedule

Schedule Type: Short stays with returns
Study Length: One - 3 Night Stay, Two - 2 Night Stays, One - 5 Night Stay & 5 Returns

Screening Dates: (appointments available in Omaha only)

Event Day Event Date
Tuesday 4/29/2025
Friday 5/2/2025
Wednesday 5/7/2025
Friday 5/9/2025
Monday 5/12/2025

Doctor Exam Dates: (appointments available in Omaha only)

Event Day Event Date
Tuesday 4/29/2025
Friday 5/2/2025
Wednesday 5/7/2025
Friday 5/9/2025
Monday 5/12/2025

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Tuesday 5/13/2025 3:00:00 PM Friday 5/16/2025 10:00:00 AM 1 Lincoln
Check-In Wednesday 5/21/2025 6:00:00 AM Friday 5/23/2025 10:00:00 PM 1 Lincoln
Check-In Wednesday 5/28/2025 6:00:00 AM Friday 5/30/2025 10:00:00 PM 1 Lincoln
Check-In Wednesday 6/4/2025 6:00:00 AM Monday 6/9/2025 10:00:00 AM 1 Lincoln
Return Wednesday 6/11/2025 7:30:00 AM Wednesday 6/11/2025 9:30:00 AM 1 Lincoln
Return Saturday 6/14/2025 8:30:00 AM Saturday 6/14/2025 9:30:00 AM 1 Lincoln
Return Wednesday 6/18/2025 8:30:00 AM Wednesday 6/18/2025 9:30:00 AM 1 Lincoln
Return Wednesday 6/25/2025 8:30:00 AM Wednesday 6/25/2025 9:30:00 AM 1 Lincoln
Return Wednesday 7/2/2025 7:30:00 AM Wednesday 7/2/2025 9:30:00 AM 1 Lincoln